Examining prescription drug importation: a review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002, Volume 4
U.S. G.P.O., 2002 - Law - 112 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
adulterated affordable allow Amgen antibiotics approved assure Bilirakis bill border Buyer Canadian Canadian pharmacy Chairman Tauzin citizens Combivir committee concerned Congress controlled substances Copeland counterfeit drugs counterfeit product Customs distributors Drug Importation Drug Marketing Act drug products drugs from Canada Epogen FD&C FD&C Act FDA-approved drugs FDA's Food and Drug foreign going Gutknecht hearing Hubbard Hutt illegal individuals Internet issue John Thune Kingston labeling legislation licensed macist manufactured Medicare medications medicines Mexico Michael Bilirakis misbranded Norwood Nutropin Okay packages Pallone patient PDMA percent personal importation Peter Barton Pfizer phar pharmaceutical pharmacies pharmacist PhRMA physician Prepared Statement price discrimination problem public health purchase question regulatory reimported drugs requirements risk safe and effective safety scription drugs seniors Serono Shepherd standards Strickland Stupak Subcommittee sumers talking tell Thank things tion unapproved United unsafe Wennar wholesalers